Update on the treatment of Pseudomonas aeruginosa pneumonia.
about
A novel virulence strategy for Pseudomonas aeruginosa mediated by an autotransporter with arginine-specific aminopeptidase activityMulti-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative BacteriaPrevalence and analysis of Pseudomonas aeruginosa in chinchillasStructural changes and differentially expressed genes in Pseudomonas aeruginosa exposed to meropenem-ciprofloxacin combination.nBioChip, a Lab-on-a-Chip Platform of Mono- and Polymicrobial Biofilms for High-Throughput Downstream Applications.A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa.Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro.Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosa pneumoniaVE-cadherin cleavage by LasB protease from Pseudomonas aeruginosa facilitates type III secretion system toxicity in endothelial cells.High prevalence of extended-spectrum β-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India.Pseudomonas aeruginosa Ventilator-Associated Pneumonia Induces Lung Injury through TNF-α/c-Jun NH2-Terminal Kinase Pathways.Antibacterial efficacy of temperate phage-mediated inhibition of bacterial group motilities.Impact of antibiotic use on carbapenem resistance in Pseudomonas aeruginosa: is there a role for antibiotic diversity?Adaptation-based resistance to siderophore-conjugated antibacterial agents by Pseudomonas aeruginosaPseudomonas aeruginosa colonization enhances ventilator-associated pneumonia-induced lung injury.Successful management of multidrug-resistant Pseudomonas aeruginosa pneumonia after kidney transplantation in a dog.Emerging drugs in sepsis.Management of antibiotic resistance in the intensive care unit setting.Treatment options for multidrug-resistant nonfermenters.Inhaled ciprofloxacin for chronic airways infections caused by Pseudomonas aeruginosa.Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).The post-antibiotic era: promising developments in the therapy of infectious diseases.Liposomal antibiotic formulations for targeting the lungs in the treatment of Pseudomonas aeruginosa.Implications and emerging control strategies for ventilator-associated infections.A clinical approach to managing Pseudomonas aeruginosa infections.The correlation between the presence of quorum sensing, toxin-antitoxin system genes and MIC values with ability of biofilm formation in clinical isolates of Pseudomonas aeruginosaManagement of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art.The inhibition of Pseudomonas aeruginosa biofilm formation by micafungin and the enhancement of antimicrobial agent effectiveness in BALB/c mice.Aloe vera Gel: Effective Therapeutic Agent against Multidrug-Resistant Pseudomonas aeruginosa Isolates Recovered from Burn Wound Infections.Analysis of integrons and associated gene cassettes in clinical isolates of multidrug resistant Pseudomonas aeruginosa from Southwest Nigeria.Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia.Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection.Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects.Coexistence of metallo-beta-lactamase-encoding genes in Pseudomonas aeruginosa.Haplotype analysis of the germacrene A synthase gene and association with cynaropicrin content and biological activities in Cynara cardunculus.Antibiotic combination efficacy (ACE) networks for a Pseudomonas aeruginosa model.Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam.Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections.Partially-desulfated heparin improves survival inPseudomonaspneumonia by enhancing bacterial clearance and ameliorating lung injuryLactobacillus salivarius reverse antibiotic-induced lung defense impairment in a ventilator model
P2860
Q28492745-6DBB7708-EA7B-49A8-98DF-9BAE13BAB095Q30431366-4D9E8F42-995F-47EC-9027-16EECA65EEC0Q30478342-F4C49169-9085-426B-A713-FF5AA327E11DQ33798601-4C4BB4EA-C877-45FD-BC43-109458A63CF6Q33849725-CEFD9253-0E84-42E0-8AED-9123653DC71AQ34074975-5777C09A-6A8A-4198-B172-2C6DB771A7CEQ34187311-91176826-C406-4E89-B651-F24DD2AFF5C5Q34479844-6270F9F9-EC89-4078-A300-65FE5EB3A7AEQ35120184-1A83FC3A-EBF1-454D-AC21-9AE711A9A485Q35938920-E2B99B95-C2A8-41D7-A2E3-9EFB87092511Q36242602-A56306F4-7FB6-458D-8642-EEEB2A6BDD1DQ36364160-B5BB25B4-EF01-4422-BBF1-3981C23435ADQ36757551-72377955-59F0-4EBD-B41D-4BB2C50874C9Q37123987-62B8F89F-D25A-40DA-A38B-8B7CBD637B9EQ37163619-B988BF05-9F17-477A-8C3F-7D24DD26321CQ37618296-44E60ABB-28BF-4A78-8BE5-6B39A173762CQ37670186-3407805D-4699-4705-BC30-C8AB58BC480AQ37700552-4569DD58-702C-4CE5-9186-549D7A148597Q37700555-7EBFE290-7E74-46E6-9445-47BEBDB41891Q38068608-6755E8CC-6B86-4053-B5DA-0F837D809220Q38070006-C0F7DFBB-3CB9-4822-86DF-282A5EE4DD3DQ38106970-94A0EBFC-C761-4977-9216-847CD48FB165Q38214155-97DCDCC2-ED34-4CCA-B09C-82B736E8A88DQ38336386-4DAAC62A-0670-46E0-B07D-3C95F0E4D7D8Q38806414-061A9DAD-B811-4A0F-953D-4697052030F0Q39520108-75F0833D-6E30-40F5-B341-3F2807B8C397Q40095692-E7C75012-0A42-4972-9018-41F8C982602DQ40635555-05A2FEE2-56C9-4309-99A9-DA2718CF002EQ41057084-BD9FDB9A-871F-4E1C-A37A-6B84815E5721Q42086148-72CB24FA-05DA-4300-8CCC-078F207BB263Q42694092-12EDC7E8-D611-4BFC-AE5F-1F3417DF3185Q44121558-11FDE3BF-1E25-40FF-A137-DBA97E8DD332Q45289238-8556E97F-DD4C-4818-9B5F-0782A0DBDB6FQ47118596-B207C38E-D1F3-4CD5-A62B-21B0BED0B972Q47396999-FB2C8F9B-B263-4297-9414-87C42485DB94Q53690104-6C0418B7-585E-4EC2-962E-B62DE2F895FEQ53702253-B7011F40-A7DE-4C7F-A824-5C7291F3C7B4Q53707227-CCA01F98-615C-4695-8B1A-2C06FC3D404FQ58326494-9C312FBE-03A4-4D4C-8560-5F7D7F5FE9F6Q58786324-9FAA8391-55D0-4D0F-BFC8-AE20A74B4466
P2860
Update on the treatment of Pseudomonas aeruginosa pneumonia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Update on the treatment of Pseudomonas aeruginosa pneumonia.
@en
Update on the treatment of Pseudomonas aeruginosa pneumonia.
@nl
type
label
Update on the treatment of Pseudomonas aeruginosa pneumonia.
@en
Update on the treatment of Pseudomonas aeruginosa pneumonia.
@nl
prefLabel
Update on the treatment of Pseudomonas aeruginosa pneumonia.
@en
Update on the treatment of Pseudomonas aeruginosa pneumonia.
@nl
P2860
P356
P1476
Update on the treatment of Pseudomonas aeruginosa pneumonia.
@en
P2093
Ahmad Alhajhusain
Ali A El Solh
P2860
P304
P356
10.1093/JAC/DKP201
P407
P577
2009-06-11T00:00:00Z